Effectiveness of collagenized xenogenic bone grafts in maxillary sinus augmentation: A multicenter prospective study

Not Applicable

Conditions: Diseases of the digestive system

Registration Number: KCT0009609

Lead Sponsor: Hallym University Medical Center

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot yet recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

1) Those who need maxillary sinus lift surgery due to severe bone defects/periodontitis/cyst (tumor) removal/maxillary sinus evaporation
2) When primary closure is possible
3) Patients who agree to participate in clinical trials and sign the informed consent form

Exclusion Criteria

1) Pregnant women
2) Patients with uncontrolled metabolic diseases (diabetes, hypertension, etc.)
3) Those who have been administered drugs that may affect bone metabolism continuously for more than 7 days within the past 6 months (e.g. Bisphosphonates, Corticosteroids, denosumab, etc.)
4) Patients with uncontrolled gingivitis, periodontitis, and dental caries
5) Patients who have received radiation therapy in the treatment area
6) Patients who need to take anticoagulants due to uncontrolled bleeding disease
7) Patients allergic to bone graft materials
8) If you smoke more than 1 pack (20 cigarettes) per day
9) If the investigator determines that participation in the clinical trial is inappropriate because it may affect other ethical or clinical trial results.

Study & Design

Study Type: Interventional Study

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bone volume and bone density evaluation on CBCT;Ratio of BL (length from elevated bone to implant bone level) and IL (length from elevated bone to implant apex) after implant placement on panoramic view

Secondary Outcome Measures